Here’s a look at what the Trump administration’s decision to cut overhead funding for biomedical research means for ...
The No. 2 in command at the National Institutes of Health, Dr. Lawrence A. Tabak, who served as acting director of the agency ...
The FDA approved brentuximab vedotin (Adcetris) in combination with lenalidomide (Revlimid) and rituximab for relapsed or ...
T he U.S. National Institutes of Health (NIH) is the largest funder of biomedical research in the world, and its grants ...
After the National Institutes of Health issued an order Friday night that would dramatically reduce funding, professor ...
The 80-year-old partnership between the federal government and research institutions has made the U.S. the leader in ...
Trump’s pick for HHS secretary has his sights on halting infectious disease research.
The National Institutes of Health’s indirect funding cap could halt studies and limit researchers’ ability to find cures for ...
We’re talking about massive layoffs across the Triangle if this (rule) holds,” former UNC-Chapel Hill Chancellor Holden Thorp ...
The order was temporarily blocked after Massachusetts and 21 other states filed a lawsuit opposing the NIH funding cuts.
Monday's ruling by U.S. District Judge Angel Kelley puts on hold funding caps for indirect research costs such as lab ...
A Wednesday night earnings report left big questions about how the spending reductions would affect the company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback